IP Library › Granted Patent US 12,385,908
Granted Patent B2
US 12,385,908 · App. 17/417,879 · Granted Aug 12, 2025

Size-based particle separation and concentration using particle size amplification

Inventors: Jon F. Edd (Wakefield, MA); Kaja Kaastrup (Charlestown, MA); Ravi Kapur (Sharon, MA); Mehmet Toner (Charlestown, MA)
Assignee: The General Hospital Corporation
G01N33/54366B01L3/502761G01N33/491G01N33/54313B01L2200/0652B01L2300/0636B01L2300/0816B01L2400/086
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,385,908
App. No.
17/417,879
Granted
Aug 12, 2025
Kind
B2
Abstract

Methods of using particle size amplification to facilitate size-based particle separation and concentration. At least one of the methods includes introducing a plurality of binding moieties into a fluid sample; allowing at least one of the binding moieties to bind two or more biological particles to form a particle cluster, in which the particle cluster includes a first type of biological particle bound to a second different type of biological particle; and flowing the fluid sample including the particle cluster into a particle sorting region of a microfluidic device.

Claims (25)

1. A method comprising:

introducing a plurality of binding moieties into a fluid sample comprising blood; allowing at least one of the plurality binding moieties to bind two or more biological particles to form a particle cluster, wherein the two of more biological particles of the particle cluster comprises a first type of biological particle bound to a second different type of biological particle, and wherein the first type of biological particle comprises a red blood cell, and wherein the second different type of biological particle comprises a platelet;

providing a microfluidic device having a particle sorting region, the particle sorting region defining a first microfluidic channel and a second microfluidic channel; and

flowing the fluid sample comprising the particle cluster into the particle sorting region of the microfluidic device, including dividing, using the particle sorting region, the fluid sample into a first fluid stream within the first microfluidic channel and a second fluid stream within the second microfluidic channel,

wherein dividing the fluid sample into the first fluid stream within the first microfluidic channel and the second fluid stream within the second microfluidic channel comprises applying, using the microfluidic device, a size-dependent force within the particle sorting region that is sufficient to maintain the particle cluster within the first fluid stream and away from the second fluid stream,

wherein the fluid sample comprises a third type of biological particle different from the first and second types of biological particles, and wherein flowing the fluid sample into the particle sorting region of the microfluidic device comprises flowing the third type of biological particle flews from the first fluid stream into the second fluid stream in the particle sorting region, and wherein the size-dependent force within the particle sorting region is insufficient to maintain the third type of biological particle in the first fluid stream.

2. The method of claim 1 , wherein an average size of the third type of biological particles within the fluid sample is smaller than a size of the particle cluster.

3. The method of claim 1 , wherein an average size of the second type of biological particles within the fluid sample is smaller than a size of the first type of biological particle.

4. The method of claim 2 , wherein the average size of the second type of biological particles within the fluid sample is the same as an average size of the third type of biological particle within the fluid sample.

5. The method of claim 1 , wherein the particle sorting region comprises a third microfluidic channel different from the first microfluidic channel, and

wherein the method comprises flowing a second fluid sample into the third microfluidic channel, including flowing a portion of the second fluid sample from the third microfluidic channel into the first microfluidic channel in the particle sorting region, and wherein the size-dependent force experienced by the particle cluster is sufficient to drive the particle cluster from the fluid sample into the portion of the second fluid sample in the first microfluidic channel.

6. The method of claim 5 , wherein the second fluid sample comprises a buffer solution.

7. The method of claim 1 , wherein a first binding moiety of the plurality of binding moieties binds to the first type of biological particle and a second binding moiety of the plurality of binding moieties binds to the second, different type of biological particle, and the first binding moiety binds to the second binding moiety to form the particle cluster.

8. The method of claim 7 , wherein at least one of the first binding moiety or the second binding moiety comprises an antibody or an antibody fragment.

9. The method of claim 1 , wherein a first binding moiety of the plurality of moieties binds to the first type of biological particle, a second binding moiety of the plurality of moieties binds to the second different type of biological particle, and at least a third binding moiety of the plurality of moieties binds the first binding moiety to the second binding moiety of the plurality of moieties to form the particle cluster.

10. The method of claim 9 , wherein at least one of the first binding moiety, the second binding moiety, or the third binding moiety comprises an antibody or an antibody fragment.

11. The method of claim 1 , wherein the third type of biological particle comprises a bacteria cell.

12. The method of claim 1 , wherein at least one of the plurality of binding moieties target at least one of anti-mouse IgG Fc antigens, anti-human CD41 antigens, or anti-human CD235a antigens.

13. The method of claim 1 , further comprising cleaving the particle cluster when the particle cluster reaches a predefined position in the microfluidic device such that the two or more biological particles making up the particle cluster are no longer bound to each other.

14. The method of claim 13 , wherein cleaving the particle cluster includes using at least one of light, an increase in temperature of the particle cluster, a decrease in temperature of the particular cluster, or a buffer composition.

15. The method of claim 1 , wherein the plurality of binding moieties comprises a recombinant protein.

16. The method of claim 1 , wherein the plurality of binding moieties comprises at least one of a polymer, an antibody, an antibody fragment, an aptamer, or a tetrameric antibody complex.

17. The method of claim 1 , wherein the size-dependent force comprises at least one of an inertial lift force or a deterministic lateral displacement force.

18. The method of claim 1 , wherein the size-dependent force comprises at least one of an acoustic force or a dielectric force.

19. The method of claim 1 , wherein the fluid sample comprises the first type of biological particle, the second type of biological particle and the third type of biological particle.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2022
From: EDD, JON F.; KAASTRUP, KAJA; KAPUR, RAVI; TONER, MEHMET
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 058528/0725 →
Continuity (2)
Provisional Application 62785550 · Dec 27, 2018
Related Publication 20220074932A1 · Mar 10, 2022
References Cited (36)
US 5968820A · Zborowski et al. · 1999 [cited by applicant]
US 6540896B1 · Manz et al. · 2003 [cited by applicant]
US 6767706B2 · Quake et al. · 2004 [cited by applicant]
US 8137912B2 · Kapur et al. · 2012 [cited by applicant]
US 8895298B2 · Toner · 2014 [cited by examiner]
US 9034658B2 · Barber et al. · 2015 [cited by applicant]
US 9895694B2 · Kapur · 2018 [cited by examiner]
US 10478819B2 · Kapur · 2019 [cited by examiner]
US 10875021B2 · Kapur · 2020 [cited by examiner]
US 11027280B2 · Kapur · 2021 [cited by examiner]
US 11944971B2 · Kapur · 2024 [cited by examiner]
US 20050121604A1 · Mueth · 2005 [cited by examiner]
US 20070059716A1 · Balis · 2007 [cited by examiner]
US 20070059719A1 · Grisham · 2007 [cited by examiner]
US 20070059781A1 · Kapur · 2007 [cited by examiner]
US 20070099207A1 · Fuchs · 2007 [cited by examiner]
US 20090032449A1 · Mueth · 2009 [cited by examiner]
US 20130209988A1 · Barber · 2013 [cited by examiner]
US 20160121331A1 · Kapur · 2016 [cited by examiner]
US 20160123857A1 · Kapur et al. · 2016 [cited by applicant]
US 20160123858A1 · Kapur · 2016 [cited by examiner]
US 20180161775A1 · Kapur · 2018 [cited by examiner]
US 20180361384A1 · Kapur · 2018 [cited by examiner]
US 20190137931A1 · Mueth · 2019 [cited by examiner]
US 20240052284A1 · Gachelin · 2024 [cited by examiner]
US 20240198338A1 · Kapur · 2024 [cited by examiner]
Di Carlo et al., “Continuous inertial focusing, ordering, and separation of particles in microchannels.,” Proc. Natl. Acad. Sci. U.S.A., Nov. 2007, 104(48):18892-18897. [cited by applicant]
Di Carlo et al., “Particle segregation and dynamics in confined flows,” Phys. Rev. Lett., Mar. 2009, 102(9):094503-1-094503-4. [cited by applicant]
Di Carlo, “Inertial microfluidics,” Lab Chip, 2009, 9(21):3038-3046. [cited by applicant]
International Prelminary Report on Patentability in International Appln. No. PCT/US2019/068565, mailed on Jul. 8, 2021, 7 pages. [cited by applicant]
International Seach Report and Written Opinion in International Appln. No. PCT/US2019/068565, mailed on Mar. 4, 2020, 9 pages. [cited by applicant]
Lansdorp et al., “Cyclic tetramolecular complexes of monoclonal antibodies: a new type of cross-linking reagent,” Eur J Immunol, Jun. 1986, 16(6):679-683. [cited by applicant]
Laurell et al., “Chip integrated strategies for acoustic separation and manipulation of cells and particles,” Chemical Society Reviews, 2007, 36:492-506. [cited by applicant]
Li et al., “A review of microfabrication techniques and dielectrophoretic microdevices for particle manipulation and separation,” Journal of Physics D: Applied Physics, 2014, 47(6):063001, 56 pages. [cited by applicant]
McGrath et al., “Deterministic lateral displacement for particle separation: a review,” Lab Chip, Nov. 2014, 14(21):4139-58. [cited by applicant]
Wognum et al., “Use of Tetrameric Antibody Complexes to Stain Cells for Flow Cytometry,” Cytometry, 1987, 8:366-71. [cited by applicant]